Mega Lifesciences PCL (BKK:MEGA)

Market Cap	28.99B
Revenue (ttm)	15.88B
Net Income (ttm)	1.85B
Shares Out	871.87M
EPS (ttm)	2.12
PE Ratio	15.72
Forward PE	11.39
Dividend	1.60 (4.81%)
Ex-Dividend Date	n/a

Volume	1,357,038
Average Volume	684,315
Open	32.25
Previous Close	32.25
Day's Range	31.75 - 33.75
52-Week Range	29.75 - 43.75
Beta	0.51
RSI	56.80
Earnings Date	Feb 21, 2025

About Mega Lifesciences PCL

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-bei...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 900
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: MEGA

Financial Performance

In 2023, Mega Lifesciences PCL's revenue was 15.72 billion, a decrease of -0.07% compared to the previous year's 15.73 billion. Earnings were 1.99 billion, a decrease of -11.10%.